ITGA2 and lung adenocarcinoma: As expected, EGFR (Fig. 12B), ITGA2, KRAS, MMP9, NRAS and MAPK13 (Figures S28B, S32B–35B) had higher levels in lung adenocarcinoma than in normal lung tissues.